Legal & General Group Plc - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,053
-69.3%
2,565
-18.0%
0.00%
Q2 2023$19,747
+9.5%
3,1270.0%0.00%
Q1 2023$18,027
-43.8%
3,1270.0%0.00%
Q4 2022$32,083
-38.3%
3,1270.0%0.00%
Q3 2022$52,000
+15.6%
3,127
-3.7%
0.00%
Q2 2022$45,000
+9.8%
3,247
+28.0%
0.00%
Q1 2022$41,000
-22.6%
2,536
+3.0%
0.00%
Q4 2021$53,000
+178.9%
2,463
+93.0%
0.00%
Q3 2021$19,000
-26.9%
1,2760.0%0.00%
Q2 2021$26,000
-98.6%
1,276
-97.9%
0.00%
-100.0%
Q1 2021$1,830,00060,5000.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders